Immunogenicity and its effects: underlying mechanisms

Go to course
Immunogenicity and its effects: underlying mechanisms

About the program

This programme entitled ‘Immunogenicity Online’ provides a comprehensive learning tool designed by an international faculty to reflect the range of new insights and data on immunogenicity in rheumatoid arthritis and its implications for clinical practice.  Covering topics from the underlying mechanisms of immunogenicity through to the recognition and management of immunogenicity in the clinic, this program is highly interactive and easy to use to facilitate learning.

The target audience for this program is physicians, rheumatologists and other healthcare professionals with an interest in rheumatic disease.

CME ACCREDITATION 

uems-logo

The e-learning activity Immunogenicity Online made available on http://www.intmedpress.com/immunogenicity-online and organized by International Medical Press is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists.

The e-learning activity  Immunogenicity Online, made available on http://www.intmedpress.com/immunogenicity-online and organized by International Medical Press, is awarded 1 European CME credits (ECMEC’s).

Each medical specialist should claim only those credits that he/she actually spent in the educational activity. The EACCME is an institution of the European Union of Medical Specialists (UEMS). Only those e-learning materials that are displayed on the UEMS-EACCME website have formally been accredited.

Through an agreement between the European Union of Medical Specialists (UEMS) and the American Medical Association (AMA), physicians may convert EACCME credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME credit to AMA credit can be found at www.ama-assn.org/go/internationalcme.

Meet the faculty

‘Immunogenicity Online’ has been developed by faculty committed to improving outcomes for people with rheumatic disease:

  • Ernest Choy, UK
  • GertJan Wolbink, the Netherlands
  • Daniel Furst, USA

Read more